{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T20:42:35Z","timestamp":1649018555846},"reference-count":32,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,5,24]]},"DOI":"10.1253\/circj.cj-18-1304","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T22:04:33Z","timestamp":1555970673000},"page":"1239-1246","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Clinical Outcome of Drug-Eluting vs. Bare-Metal Stent Implantation After Percutaneous Coronary Intervention in End-Stage Renal Disease Patients on Hemodialysis\u3000\u2015 Nationwide Cohort Study in Taiwan \u2015"],"prefix":"10.1253","volume":"83","author":[{"given":"Mei-Ling","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Lun","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Tzu Chi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Yu-Chih","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Buddhist Tzu Chi General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Cheng","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Tzu Chi University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Wetmore JB, Collins AJ. Global challenges posed by the growth of end-stage renal disease. <i>Ren Replace Ther<\/i> 2016; 2: 15.","DOI":"10.1186\/s41100-016-0021-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Chen DY, Mao CT, Tsai ML, Hsieh MJ, Lin YS, Cherng WJ, et al. Clinical outcomes of drug-eluting stents vs. bare-metal stents in acute myocardial infarction patients under dialysis: A nationwide cohort study. <i>Circ J<\/i> 2016; 80: 363\u2013370.","DOI":"10.1253\/circj.CJ-15-0778"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Otsuka Y, Ishiwata S, Inada T, Kanno H, Kyo E, Hayashi Y, et al. Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: Insights from the Japan multi-centre post-marketing surveillance registry. <i>Eur Heart J<\/i> 2011; 32: 829\u2013837.","DOI":"10.1093\/eurheartj\/ehq480"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sarnak M, Andrew L, Schoolwerth A, Coresh J, Culleton B, Hamm L, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. <i>Circulation<\/i> 2003; 108: 2154\u20132169.","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. <i>Nephrol Dial Transpl<\/i> 2000; 15: 218\u2013223.","DOI":"10.1093\/ndt\/15.2.218"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shroff GR, Solid CA, Herzog CA. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the united states. <i>Circulation<\/i> 2013; 127: 1861\u20131869.","DOI":"10.1161\/CIRCULATIONAHA.112.001264"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Li S, Ye D, Chen G, Xu W. Meta-analysis of comparison of drug-eluting stents and bare-metal stents in patients on dialysis. <i>Am J Cardiol<\/i> 2017; 119: 1186\u20131192.","DOI":"10.1016\/j.amjcard.2016.12.036"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chang TI, Montez-Rath ME, Tsai TT, Hlatky MA, Winkelmayer WC. Drug-eluting versus bare-metal stents during PCI in patients with end-stage renal disease on dialysis. <i>J Am Coll Cardiol<\/i> 2016; 67: 1459\u20131469.","DOI":"10.1016\/j.jacc.2015.10.104"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, et al. Short-and long-term outcomes with drug-eluting and bare-metal coronary stents: A mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. <i>Circulation<\/i> 2012; 125: 2873\u20132891.","DOI":"10.1161\/CIRCULATIONAHA.112.097014"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. K\/DOQI Workgroup. K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. <i>Am J Kidney Dis<\/i> 2005; 45: 16\u2013153.","DOI":"10.1053\/j.ajkd.2005.01.019"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. <i>Kidney Int<\/i> 2006; 70: 2021\u20132030.","DOI":"10.1038\/sj.ki.5001934"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tsai TT, Messenger JC, Brennan JM, Patel UD, Dai D, Piana RN, et al. Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: A report from the linked CathPCI Registry-CMS claims database. <i>J Am Coll Cardiol<\/i> 2011; 58: 1859\u20131869.","DOI":"10.1016\/j.jacc.2011.06.056"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ishii H, Toriyama T, Aoyama T, Takahashi H, Tanaka M, Yoshikawa D, et al. Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients. <i>Circ J<\/i> 2012; 76: 1609\u20131615.","DOI":"10.1253\/circj.CJ-12-0078"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lee HF, Wu LS, Chan YH, Lee CH, Liu JR, Tu HT, et al. Dialysis patients with implanted drug-eluting stents have lower major cardiac events and mortality than those with implanted bare-metal stents: A Taiwanese nationwide cohort study. <i>PLoS One<\/i> 2016; 11: e0146343.","DOI":"10.1371\/journal.pone.0146343"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Okada T, Hayashi Y, Toyofuku M, Imazu M, Otsuka M, Sakuma T, et al. One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. <i>Circ J<\/i> 2008; 72: 1430\u20131435.","DOI":"10.1253\/circj.CJ-08-0010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tsujita H, Hamazaki Y, Nishikura T, Yokota H, Kondo S, Hosokawa S, et al. Sirolimus-eluting stents versus paclitaxel-eluting stents for coronary intervention in patients with renal failure on hemodialysis. <i>Cardiovasc Interv Ther<\/i> 2013; 28: 9\u201315.","DOI":"10.1007\/s12928-012-0103-6"},{"key":"17","unstructured":"17. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. <i>J Invasive Cardiol<\/i> 2006; 18: 405\u2013408."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ichimoto E, Kobayashi Y, Iijima Y, Kuroda N, Kohno Y, Komuro I, et al. Long-term clinical outcomes after sirolimus-eluting stent implantation in dialysis patients. <i>Int Heart J<\/i> 2010; 51: 92\u201397.","DOI":"10.1536\/ihj.51.92"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. <i>Circ J<\/i> 2007; 71: 1525\u20131529.","DOI":"10.1253\/circj.71.1525"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kim BK, Oh S, Jeon DW, Yang JY, Kim JS, Park S, et al. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: Results of Korean Multicenter Angioplasty Team (KOMATE) Registry: Coronary artery disease. <i>J Interv Cardiol<\/i> 2009; 22: 411\u2013419.","DOI":"10.1111\/j.1540-8183.2009.00495.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tomai F, Ribichini F, De Luca L, Petrolini A, Ghini AS, Weltert L, et al. Randomized comparison of Xience V and multi-link vision coronary stents in the same multivessel patient with chronic kidney disease (RENAL-DES) study. <i>Circulation<\/i> 2014; 129: 1104\u20131112.","DOI":"10.1161\/CIRCULATIONAHA.113.005186"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Garg P, Charytan DM, Novack L, Cutlip DE, Popma JJ, Moses J, et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials). <i>Am J Cardiol<\/i> 2010; 106: 1436\u20131442.","DOI":"10.1016\/j.amjcard.2010.07.011"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Halkin A, Mehran R, Casey CW, Gordon P, Matthews R, Wilson BH, et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS-IV Trial. <i>Am Heart J<\/i> 2005; 150: 1163\u20131170.","DOI":"10.1016\/j.ahj.2005.01.032"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. <i>Circ J<\/i> 2008; 72: 56\u201360.","DOI":"10.1253\/circj.72.56"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yachi S, Tanabe K, Tanimoto S, Aoki J, Nakazawa G, Yamamoto H, et al. Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. <i>Am J Kidney Dis<\/i> 2009; 54: 299\u2013306.","DOI":"10.1053\/j.ajkd.2009.01.263"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Rosenblum MA, Robbins MJ, Farkouh ME, Winston JA, Kim MC. Diminished benefits of drug-eluting stents versus bare metal stents in patients with severe renal insufficiency. <i>Nephron Clin Pract<\/i> 2009; 113: 198\u2013203.","DOI":"10.1159\/000232602"},{"key":"27","unstructured":"27. Silva LS, Oliveira RA, Silva GB, Lima JW, Silva RP, Liborio AB, et al. Cardiovascular disease in patients with end-stage renal disease on hemodialysis in a developing country. <i>Saudi J Kidney Dis Transpl<\/i> 2012; 23: 262\u2013266."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Zoccali C, Mallamaci F, Tripepi G. Inflammation and atherosclerosis in end-stage renal disease. <i>Blood Purif<\/i> 2003; 21: 29\u201336.","DOI":"10.1159\/000067852"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Berger PB, Bhatt DL, Fuster V, Steg PG, Fox KA, Shao M, et al. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: Results from the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (CHARISMA) trial. <i>Circulation<\/i> 2010; 121: 2575\u20132583.","DOI":"10.1161\/CIRCULATIONAHA.109.895342"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gaspari F, Vigan\u00f2 G, Orisio S, Bonati M, Livio M, Remuzzi G. Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. <i>J Clin Invest<\/i> 1987; 79: 1788\u20131797.","DOI":"10.1172\/JCI113020"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Luo JC, Leu HB, Huang KW, Huang CC, Hou MC, Lin HC, et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. <i>CMAJ<\/i> 2011; 183: E1345\u2013E1351.","DOI":"10.1503\/cmaj.110299"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Otsuka M, Shiode N, Masaoka Y, Okimoto T, Tamekiyo H, Kawase T, et al. Comparison of everolimus- and paclitaxel-eluting stents in dialysis patients. <i>Cardiovasc Revasc Med<\/i> 2015; 16: 208\u2013212.","DOI":"10.1016\/j.carrev.2015.04.005"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/6\/83_CJ-18-1304\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T03:17:51Z","timestamp":1558754271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/6\/83_CJ-18-1304\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-18-1304","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]}}}